Aidspan - Iran (Islamic Republic)

Global Fund Grants to Iran (Islamic Republic) as of 31 August 2010

The information provided here is based on data available from the Global Fund website. Based on that data, we provide a comparative evaluation of how each grant performed during its first 2 years (Phase 1). Performance information for later years is also provided but has not been evaluated. Aidspan is currently developing a more comprehensive evaluation methodology which will provide comparative analyses of grant performance during every phase: Phase 1 (Years 1-2), Phase 2 (Years 3-5) and Rolling Continuation Channel (RCC) covering subsequent years.

All money amounts are in US dollars. Grants are rated by Aidspan according to the following color-coded scheme:

A: On or ahead of schedule

B: Up to 3 months behind

C: 3 to 6 months behind

D: Over 6 months behind

N: Not rated

Global Fund grants to Iran (Islamic Republic)

4 grants, worth a total of $80,218,868, as follows:

	Phase 1 - Years 1-2	Year 3 Onwards	Total
HIV/AIDS	$14,993,097 (agreed)	$32,251,238 (projected)	$47,244,335 (projected)
TB	$12,652,286 (agreed)	$9,122,942 (projected)	$21,775,228 (projected)
Malaria	$5,615,598 (agreed)	$5,583,707 (projected)	$11,199,305 (projected)
Total	$33,260,981 (agreed)	$46,957,887 (projected)	$80,218,868 (projected)
Disbursed	$24,889,131 (75%)	$9,396,431 (20%)	$34,285,562 (43%)

Performance of Iran (Islamic Republic) grants

A: Grants on or ahead of schedule

B:	On average, the Iran (Islamic Republic) grants are 1.7 months behind schedule

B: Grants up to 3 months behind schedule

C: Grants 3 to 6 months behind schedule

D: Grants over 6 months behind schedule

N: Grants not rated by Aidspan

Total number of grants:

Global Fund links for Iran (Islamic Republic)

Data regarding HIV/AIDS, TB and malaria in Iran (Islamic Republic)

Country-specific Data Sheet on HIV, TB and malaria from www.GlobalHealthFacts.org (a service of Kaiser Family Foundation, using data from UN and other sources)
Country-specific Epidemiological Fact Sheet on HIV from WHO

In the table below, click on any grant to see that grant's background details and progress to date

Round /
NSA Wave

Disease Component

Applicant

Title

Grant Number
(Click for details)

Principal Recipient

Current Status

Phase 1 - Years 1-2

Phase 2 - Years 3-5

Phase 1 + Phase 2

Disbursed so far

Phase 1 rating:
Months ahead of or behind schedule

Round 2

HIV/AIDS

CCM

The prevention and control of HIV/AIDS, TB and Malaria in I.R. Iran through public, civil society and private partnerships

IRN-202-G01-H

The United Nations Development Programme

Phase 1 approved. Agreement signed. Fully disbursed.

Phase 2 approved. Agreement signed. 92% disbursed.

P1 (agreed) :	$5,698,000
P2 (agreed) :	$10,224,855
P1+P2 (agreed) :	$15,922,855
Disbursed:	$15,094,431

D: 7.6 months behind

Round 7

Malaria

CCM

Malaria Intensified Control In High Burden Provinces of South Eastern Iran

IRN-708-G02-M

The United Nations Development Programme

Phase 1 approved. Agreement signed. 96% disbursed.

Phase 2 not yet approved. No disbursements yet.

P1 (agreed) :	$5,615,598
P2 (projected) :	$5,583,707
P1+P2 (projected) :	$11,199,305
Disbursed:	$5,398,911

B: 2.5 months behind

Round 7

CCM

Tuberculosis Prevention In High Burden Areas, Islamic Republic of Iran

IRN-708-G03-T

The United Nations Development Programme

Phase 1 approved. Agreement signed. 96% disbursed.

Phase 2 not yet approved. No disbursements yet.

P1 (agreed) :	$12,652,286
P2 (projected) :	$9,122,942
P1+P2 (projected) :	$21,775,228
Disbursed:	$12,121,310

B: 2.5 months behind

Round 8

HIV/AIDS

CCM

Scaling Up HIV/AIDS Prevention Programs Towards Universal Access with Increasing the Partnership of Non-Government Sector

IRN-810-G04-H

The United Nations Development Programme

Phase 1 approved. Agreement signed. 18% disbursed.

Phase 2 not yet approved. No disbursements yet.

P1 (agreed) :	$9,295,097
P2 (projected) :	$22,026,383
P1+P2 (projected) :	$31,321,480
Disbursed:	$1,670,911

A: 5.6 months ahead

Round 1 grants were approved by the Fund's board on 24 April 2002, Round 2 grants were approved on 31 January 2003, Round 3 grants were approved on 17 October 2003, Round 4 grants were approved on 30 June 2004, Round 5 grants were approved on 30 September 2005, Round 6 grants were approved on 3 November 2006, Round 7 grants were approved on 13 November 2007, Round 8 grants were approved on 8 November 2008, Round 9 grants were approved on 11 November 2009, and Wave 1 NSA grants were approved on 11 November 2009

The Global Fund bears no responsibility for this analysis. The computation of months ahead of or behind schedule was conducted by Aidspan using disbursement data obtained from the Global Fund's website.

Aidspan (www.aidspan.org, info@aidspan.org) is publisher of Global Fund Observer.